Safety overview of new disease-modifying antirheumatic drugs.

  title={Safety overview of new disease-modifying antirheumatic drugs.},
  author={John J. Cush},
  journal={Rheumatic diseases clinics of North America},
  volume={30 2},
  pages={237-55, v}
  • John J. Cush
  • Published 2004 in Rheumatic diseases clinics of North America
Beginning in 1998, a surge of new agents has expanded treatment options for rheumatoid arthritis (RA) patients. Although the disease modifying potential of these agents is encouraging, their use must be weighed against an evolving array of new safety concerns. Because of the popularity of these agents with patients and rheumatologists alike, clinicians must be prepared to discuss the potential risks associated with novel disease-modifying antirheumatic drugs and biologic therapies as they begin… CONTINUE READING

From This Paper

Topics from this paper.
13 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 13 extracted citations

Similar Papers

Loading similar papers…